Group items tagged

Study found that elevated kappa and lambda light chains (sFLC's), as well as cytopenias, elevated Beta-2 macroglobulinemia correlated with poor response.

Free Light Chains are useful in monitoring treatment success in Waldenstrom's Macroglobulinemia. On average, a response was seen 1 month earlier with the sFLC's than in the IgM. Also, appx 50% of patients receive rituxin had an IgM flare early in treatment.

Resveratrol and Simvastatin found to be helpful in lowering IgM levels in Asymptomatic patients with Waldenstrom's lymphoma

Interesting case study of sclerotic bone lesion in Waldenstrom's Macroglobulinemia.

IgM levels > 60 g/l found to predict need for plasmapheresis due to hyperviscosity syndrome.

great case study read on hyperviscosity syndrome.

Serum Free light chains helpful in the determination of prognosis and therapeutic response in patients with Waldenstrom's Macroglobulinemia.

Interesting study that highlights the complexities between Waldenstrom's Macroglobulinemia and other B-cell lymphoma's. These authors concluded that sFLC's correlated better with treatment outcomes than IgM levels.

Interesting case study of initiate presentation of Waldenstrom's Macroglobulinemia.

Great review of waldenstrom's macroglobulinemia.

A must read on waldenstrom's macroglobulinemia.

Nice brief synopsis of Waldenstrom's Macroglobulinemia.

Case study of patient with Waldenstrom's macroglobulinemia

Waldenstrom's macroglobulinemia with osteolytic bone lesions.

waldenstrom's macroglobulinemia found to have 24% bone disease.

Waldentstrom's macroglobulinemia with lytic bone lesions.  Only abstract available here.  Treatment, other than chemo, is radiation to effected site.